Clinical Trial Update: AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating AK112 in combination with chemotherapy as first-line therapy for advanced esophageal squamous cell carcinoma and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• AK112

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: ESCC, Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING